2 datasets found
  1. M

    Medical Biotechnology Has Revolutionized the Field of Medicine

    • media.market.us
    Updated Jul 19, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Market.us Media (2024). Medical Biotechnology Has Revolutionized the Field of Medicine [Dataset]. https://media.market.us/medical-biotechnology-has-revolutionized-the-field-of-medicine/
    Explore at:
    Dataset updated
    Jul 19, 2024
    Dataset authored and provided by
    Market.us Media
    License

    https://media.market.us/privacy-policyhttps://media.market.us/privacy-policy

    Time period covered
    2022 - 2032
    Description

    Editor’s Choice

    • The global biopharmaceuticals market size is expected to be worth around USD 566 billion by 2032 from USD 263 billion in 2022, growing at a CAGR of 8.2% during the forecast period from 2022 to 2032.

    • The overall success rate for phase I trials is around 16%, while for phase II trials it is around 10%. Phase III trials, which involve larger patient populations, have a success rate of around 25%.

    • The average cost of bringing a new drug to market is projected to be around USD 2.6 billion.

    • The National Genome Institute estimates that the cost of sequencing a human genome has fallen from around USD 100 million in 2001 to less than USD 1,000 in recent years.

    • In 2020, WIPO received over 23,500 biotechnology-related patent applications, demonstrating the growing innovation and research in the field.

    • The US biotechnology industry employed over 2.1 million people in 2020, including direct and indirect jobs.

  2. M

    Medical Biotechnology Statistics 2025 By Growth, Advancements, Gene Editing

    • media.market.us
    Updated Jan 13, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Market.us Media (2025). Medical Biotechnology Statistics 2025 By Growth, Advancements, Gene Editing [Dataset]. https://media.market.us/medical-biotechnology-statistics/
    Explore at:
    Dataset updated
    Jan 13, 2025
    Dataset authored and provided by
    Market.us Media
    License

    https://media.market.us/privacy-policyhttps://media.market.us/privacy-policy

    Time period covered
    2022 - 2032
    Description

    Editor’s Choice

    • The global biopharmaceuticals market size is expected to be worth around USD 566 billion by 2032 from USD 263 billion in 2022, growing at a CAGR of 8.2% during the forecast period from 2022 to 2032.

    • The overall success rate for phase I trials is around 16%, while for phase II trials it is around 10%. Phase III trials, which involve larger patient populations, have a success rate of around 25%.

    • The average cost of bringing a new drug to market is projected to be around USD 2.6 billion.

    • The National Genome Institute estimates that the cost of sequencing a human genome has fallen from around USD 100 million in 2001 to less than USD 1,000 in recent years.

    • In 2020, WIPO received over 23,500 biotechnology-related patent applications, demonstrating the growing innovation and research in the field.

    • The US biotechnology industry employed over 2.1 million people in 2020, including direct and indirect jobs.

    (Source: Journal of Clinical Oncology, Journal of Health Economics, World Intellectual Property Organization, Biotechnology Innovation Organization)

    https://www.news.market.us/wp-content/uploads/2023/06/imagebf.png" alt="Medical Biotechnology Statistics" class="wp-image-6721">

  3. Not seeing a result you expected?
    Learn how you can add new datasets to our index.

Share
FacebookFacebook
TwitterTwitter
Email
Click to copy link
Link copied
Close
Cite
Market.us Media (2024). Medical Biotechnology Has Revolutionized the Field of Medicine [Dataset]. https://media.market.us/medical-biotechnology-has-revolutionized-the-field-of-medicine/

Medical Biotechnology Has Revolutionized the Field of Medicine

Explore at:
Dataset updated
Jul 19, 2024
Dataset authored and provided by
Market.us Media
License

https://media.market.us/privacy-policyhttps://media.market.us/privacy-policy

Time period covered
2022 - 2032
Description

Editor’s Choice

  • The global biopharmaceuticals market size is expected to be worth around USD 566 billion by 2032 from USD 263 billion in 2022, growing at a CAGR of 8.2% during the forecast period from 2022 to 2032.

  • The overall success rate for phase I trials is around 16%, while for phase II trials it is around 10%. Phase III trials, which involve larger patient populations, have a success rate of around 25%.

  • The average cost of bringing a new drug to market is projected to be around USD 2.6 billion.

  • The National Genome Institute estimates that the cost of sequencing a human genome has fallen from around USD 100 million in 2001 to less than USD 1,000 in recent years.

  • In 2020, WIPO received over 23,500 biotechnology-related patent applications, demonstrating the growing innovation and research in the field.

  • The US biotechnology industry employed over 2.1 million people in 2020, including direct and indirect jobs.

Search
Clear search
Close search
Google apps
Main menu